CN Stock MarketDetailed Quotes

603520 Zhejiang Starry Pharmaceutical

Watchlist
  • 11.43
  • -0.03-0.26%
Market Closed Apr 23 15:00 CST
3.91BMarket Cap-69695P/E (TTM)

Zhejiang Starry Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
(Q6)Jun 30, 2021
Total operating revenue
18.43%1.63B
15.00%1.08B
9.40%565.91M
6.57%2.13B
5.07%1.38B
10.22%942.47M
42.08%517.3M
46.29%2B
25.25%1.31B
18.43%855.1M
Operating revenue
18.43%1.63B
15.00%1.08B
9.40%565.91M
6.57%2.13B
5.07%1.38B
10.22%942.47M
42.08%517.3M
46.29%2B
25.25%1.31B
18.43%855.1M
Other operating revenue
----
-1.08%133.12M
----
108.06%263.61M
----
443.74%134.57M
----
1,026.74%126.7M
----
18,902.47%24.75M
Total operating cost
14.67%1.59B
17.11%1.05B
25.53%555.02M
29.84%2.1B
33.33%1.39B
36.31%900.29M
51.43%442.15M
48.67%1.61B
30.24%1.04B
22.66%660.48M
Operating cost
20.98%1.23B
24.29%828.49M
26.55%449.8M
29.30%1.62B
30.06%1.02B
36.17%666.59M
75.12%355.45M
63.50%1.25B
40.10%784.46M
28.91%489.51M
Operating tax surcharges
26.11%14.6M
26.63%10.72M
2.30%5.43M
-6.36%14.56M
-0.97%11.58M
12.31%8.46M
40.38%5.31M
18.77%15.55M
-1.46%11.69M
0.96%7.53M
Operating expense
13.60%64.27M
18.29%42M
221.76%18.95M
259.88%70.81M
421.02%56.57M
364.64%35.5M
106.95%5.89M
102.53%19.68M
43.31%10.86M
55.06%7.64M
Administration expense
-14.05%91.38M
-13.96%60.58M
-26.49%25.81M
11.15%145.49M
10.54%106.32M
1.91%70.42M
15.49%35.11M
-6.78%130.89M
-7.09%96.18M
14.58%69.1M
Financial expense
-14.22%84.92M
-17.71%47.36M
62.43%20.18M
58.61%113.79M
73.23%98.99M
70.87%57.55M
-54.30%12.42M
3.85%71.74M
-5.40%57.14M
-32.51%33.68M
-Interest expense (Financial expense)
23.97%79.29M
23.75%50.07M
70.69%25.89M
25.44%92.6M
10.04%63.96M
8.97%40.46M
-20.96%15.17M
-19.79%73.82M
-11.95%58.13M
-13.21%37.12M
-Interest Income (Financial expense)
26.36%-5.34M
44.18%-3.92M
-111.00%-2.12M
-70.06%-9.7M
-36.54%-7.25M
-83.55%-7.02M
51.13%-1M
-45.59%-5.7M
-109.82%-5.31M
-238.59%-3.82M
Research and development
8.46%103.55M
5.50%65.17M
24.58%34.84M
6.44%132.61M
17.06%95.47M
16.52%61.77M
12.72%27.97M
41.82%124.58M
43.87%81.56M
46.67%53.01M
Credit Impairment Loss
82.95%4.2M
201.32%3.49M
62.58%-2.31M
92.13%-747.97K
123.74%2.3M
43.47%-3.45M
-96.66%-6.17M
-165.80%-9.51M
-8,196.57%-9.68M
-22.90%-6.1M
Asset Impairment Loss
-1,743.26%-10.28M
-1,010.59%-6.71M
---546.77K
-3,834.39%-124.61M
79.05%-557.86K
33.40%-604.08K
----
-101.99%-3.17M
-580.37%-2.66M
-131.71%-906.97K
Other net revenue
-89.79%5.65M
-87.92%5.42M
-105.36%-987.96K
-739.36%-90.98M
631.00%55.38M
541.65%44.9M
135.07%18.42M
11.91%14.23M
-23.74%7.58M
2,162.47%7M
Fair value change income
----
----
---460.54K
453.18%876.69K
9.94%1.06M
-98.14%17.22K
----
-79.14%158.48K
--962.85K
--923.89K
Invest income
-118.00%-5.12M
-113.27%-3.79M
-110.36%-1.28M
51.22%10.93M
401.30%28.44M
910.21%28.55M
936.80%12.32M
137.24%7.23M
659.96%5.67M
278.64%2.83M
-Including: Investment income associates
-13,810.97%-4.8M
-3,008.29%-3.05M
-913.65%-993.16K
-189.94%-1.65M
-103.22%-34.49K
-111.45%-97.98K
-122.96%-97.98K
-11.08%1.83M
43.57%1.07M
14.66%855.85K
Asset deal income
-19.92%3.66M
-23.89%3.48M
-99.44%24.05K
89.64%-345.94K
262.08%4.57M
318.59%4.57M
3,649.63%4.28M
-256.48%-3.34M
-1,429.91%-2.82M
-579.72%-2.09M
Other revenue
-32.59%13.19M
-43.42%8.95M
-55.23%3.58M
0.28%22.92M
21.52%19.57M
28.11%15.82M
-13.44%8M
52.47%22.85M
67.00%16.11M
136.29%12.35M
Operating profit
0.60%43.52M
-59.81%35M
-89.42%9.9M
-113.96%-55.79M
-84.34%43.26M
-56.81%87.08M
17.07%93.57M
36.00%399.77M
7.79%276.33M
9.64%201.62M
Add:Non operating Income
-69.62%179.87K
-71.02%139.9K
-87.77%15.46K
-50.32%1.02M
7.38%592.04K
19.61%482.7K
-67.57%126.4K
-86.74%2.05M
-24.88%551.36K
-18.73%403.55K
Less:Non operating expense
-60.06%2.38M
-58.56%1.87M
-84.35%216.12K
65.50%10.63M
31.77%5.96M
22.93%4.5M
36.60%1.38M
12.42%6.43M
10.88%4.52M
28.29%3.66M
Total profit
9.04%41.32M
-59.94%33.27M
-89.49%9.7M
-116.54%-65.4M
-86.09%37.9M
-58.13%83.06M
16.41%92.32M
30.19%395.39M
7.65%272.36M
9.27%198.36M
Less:Income tax cost
-79.13%1.82M
-114.51%-2M
-93.43%374.24K
-90.06%6.52M
-83.73%8.74M
-69.82%13.77M
-61.24%5.7M
30.98%65.62M
22.44%53.73M
35.42%45.63M
Net profit
35.48%39.5M
-49.10%35.27M
-89.23%9.33M
SL-71.93M
-86.67%29.15M
-54.64%69.29M
34.08%86.62M
30.04%329.77M
4.54%218.63M
3.31%152.74M
Net profit from continuing operation
35.48%39.5M
-49.10%35.27M
-89.23%9.33M
-121.81%-71.93M
-86.67%29.15M
-54.64%69.29M
34.08%86.62M
30.04%329.77M
4.54%218.63M
3.31%152.74M
Less:Minority Profit
-98.14%178.81K
-100.11%-5.64K
-103.79%-241.92K
-34.82%3.92M
1,211.22%9.61M
278.94%5.21M
18,332.97%6.38M
-59.55%6.01M
-108.09%-864.74K
-135.65%-2.91M
Net profit of parent company owners
101.17%39.32M
-44.95%35.28M
-88.08%9.57M
-123.43%-75.85M
-91.10%19.54M
-58.83%64.08M
24.27%80.24M
35.62%323.75M
10.61%219.5M
11.43%155.65M
Earning per share
Basic earning per share
83.33%0.11
-47.37%0.1
-87.50%0.03
-123.40%-0.22
-90.63%0.06
-58.70%0.19
-7.69%0.24
-6.00%0.94
-23.81%0.64
-22.03%0.46
Diluted earning per share
83.33%0.11
-47.37%0.1
-87.50%0.03
-123.16%-0.22
-90.63%0.06
-58.70%0.19
-7.69%0.24
-5.00%0.95
-23.81%0.64
-22.03%0.46
Other composite income
-70.68%3.07M
68.15%8.03M
108.17%237.87K
392.20%9.25M
814.76%10.47M
322.97%4.78M
-234.19%-2.91M
-810.04%-3.16M
44.01%-1.46M
-219.52%-2.14M
Other composite income of parent company owners
-70.68%3.07M
68.15%8.03M
108.17%237.87K
392.20%9.25M
814.76%10.47M
322.97%4.78M
-234.19%-2.91M
-732.79%-3.16M
44.70%-1.46M
-221.71%-2.14M
Total composite income
7.43%42.57M
-41.54%43.3M
-88.58%9.56M
-119.19%-62.68M
-81.75%39.62M
-50.82%74.06M
31.34%83.71M
28.97%326.6M
5.16%217.17M
0.64%150.6M
Total composite income of parent company owners
41.22%42.39M
-37.11%43.31M
-87.32%9.81M
-120.77%-66.6M
-86.23%30.01M
-55.14%68.86M
21.39%77.33M
34.50%320.59M
11.35%218.03M
8.53%153.51M
Total composite income of minority owners
-98.14%178.81K
-100.11%-5.64K
-103.79%-241.92K
-34.82%3.92M
1,211.22%9.61M
278.94%5.21M
18,332.97%6.38M
-59.64%6.01M
-108.07%-864.74K
-135.51%-2.91M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021(Q6)Jun 30, 2021
Total operating revenue 18.43%1.63B15.00%1.08B9.40%565.91M6.57%2.13B5.07%1.38B10.22%942.47M42.08%517.3M46.29%2B25.25%1.31B18.43%855.1M
Operating revenue 18.43%1.63B15.00%1.08B9.40%565.91M6.57%2.13B5.07%1.38B10.22%942.47M42.08%517.3M46.29%2B25.25%1.31B18.43%855.1M
Other operating revenue -----1.08%133.12M----108.06%263.61M----443.74%134.57M----1,026.74%126.7M----18,902.47%24.75M
Total operating cost 14.67%1.59B17.11%1.05B25.53%555.02M29.84%2.1B33.33%1.39B36.31%900.29M51.43%442.15M48.67%1.61B30.24%1.04B22.66%660.48M
Operating cost 20.98%1.23B24.29%828.49M26.55%449.8M29.30%1.62B30.06%1.02B36.17%666.59M75.12%355.45M63.50%1.25B40.10%784.46M28.91%489.51M
Operating tax surcharges 26.11%14.6M26.63%10.72M2.30%5.43M-6.36%14.56M-0.97%11.58M12.31%8.46M40.38%5.31M18.77%15.55M-1.46%11.69M0.96%7.53M
Operating expense 13.60%64.27M18.29%42M221.76%18.95M259.88%70.81M421.02%56.57M364.64%35.5M106.95%5.89M102.53%19.68M43.31%10.86M55.06%7.64M
Administration expense -14.05%91.38M-13.96%60.58M-26.49%25.81M11.15%145.49M10.54%106.32M1.91%70.42M15.49%35.11M-6.78%130.89M-7.09%96.18M14.58%69.1M
Financial expense -14.22%84.92M-17.71%47.36M62.43%20.18M58.61%113.79M73.23%98.99M70.87%57.55M-54.30%12.42M3.85%71.74M-5.40%57.14M-32.51%33.68M
-Interest expense (Financial expense) 23.97%79.29M23.75%50.07M70.69%25.89M25.44%92.6M10.04%63.96M8.97%40.46M-20.96%15.17M-19.79%73.82M-11.95%58.13M-13.21%37.12M
-Interest Income (Financial expense) 26.36%-5.34M44.18%-3.92M-111.00%-2.12M-70.06%-9.7M-36.54%-7.25M-83.55%-7.02M51.13%-1M-45.59%-5.7M-109.82%-5.31M-238.59%-3.82M
Research and development 8.46%103.55M5.50%65.17M24.58%34.84M6.44%132.61M17.06%95.47M16.52%61.77M12.72%27.97M41.82%124.58M43.87%81.56M46.67%53.01M
Credit Impairment Loss 82.95%4.2M201.32%3.49M62.58%-2.31M92.13%-747.97K123.74%2.3M43.47%-3.45M-96.66%-6.17M-165.80%-9.51M-8,196.57%-9.68M-22.90%-6.1M
Asset Impairment Loss -1,743.26%-10.28M-1,010.59%-6.71M---546.77K-3,834.39%-124.61M79.05%-557.86K33.40%-604.08K-----101.99%-3.17M-580.37%-2.66M-131.71%-906.97K
Other net revenue -89.79%5.65M-87.92%5.42M-105.36%-987.96K-739.36%-90.98M631.00%55.38M541.65%44.9M135.07%18.42M11.91%14.23M-23.74%7.58M2,162.47%7M
Fair value change income -----------460.54K453.18%876.69K9.94%1.06M-98.14%17.22K-----79.14%158.48K--962.85K--923.89K
Invest income -118.00%-5.12M-113.27%-3.79M-110.36%-1.28M51.22%10.93M401.30%28.44M910.21%28.55M936.80%12.32M137.24%7.23M659.96%5.67M278.64%2.83M
-Including: Investment income associates -13,810.97%-4.8M-3,008.29%-3.05M-913.65%-993.16K-189.94%-1.65M-103.22%-34.49K-111.45%-97.98K-122.96%-97.98K-11.08%1.83M43.57%1.07M14.66%855.85K
Asset deal income -19.92%3.66M-23.89%3.48M-99.44%24.05K89.64%-345.94K262.08%4.57M318.59%4.57M3,649.63%4.28M-256.48%-3.34M-1,429.91%-2.82M-579.72%-2.09M
Other revenue -32.59%13.19M-43.42%8.95M-55.23%3.58M0.28%22.92M21.52%19.57M28.11%15.82M-13.44%8M52.47%22.85M67.00%16.11M136.29%12.35M
Operating profit 0.60%43.52M-59.81%35M-89.42%9.9M-113.96%-55.79M-84.34%43.26M-56.81%87.08M17.07%93.57M36.00%399.77M7.79%276.33M9.64%201.62M
Add:Non operating Income -69.62%179.87K-71.02%139.9K-87.77%15.46K-50.32%1.02M7.38%592.04K19.61%482.7K-67.57%126.4K-86.74%2.05M-24.88%551.36K-18.73%403.55K
Less:Non operating expense -60.06%2.38M-58.56%1.87M-84.35%216.12K65.50%10.63M31.77%5.96M22.93%4.5M36.60%1.38M12.42%6.43M10.88%4.52M28.29%3.66M
Total profit 9.04%41.32M-59.94%33.27M-89.49%9.7M-116.54%-65.4M-86.09%37.9M-58.13%83.06M16.41%92.32M30.19%395.39M7.65%272.36M9.27%198.36M
Less:Income tax cost -79.13%1.82M-114.51%-2M-93.43%374.24K-90.06%6.52M-83.73%8.74M-69.82%13.77M-61.24%5.7M30.98%65.62M22.44%53.73M35.42%45.63M
Net profit 35.48%39.5M-49.10%35.27M-89.23%9.33MSL-71.93M-86.67%29.15M-54.64%69.29M34.08%86.62M30.04%329.77M4.54%218.63M3.31%152.74M
Net profit from continuing operation 35.48%39.5M-49.10%35.27M-89.23%9.33M-121.81%-71.93M-86.67%29.15M-54.64%69.29M34.08%86.62M30.04%329.77M4.54%218.63M3.31%152.74M
Less:Minority Profit -98.14%178.81K-100.11%-5.64K-103.79%-241.92K-34.82%3.92M1,211.22%9.61M278.94%5.21M18,332.97%6.38M-59.55%6.01M-108.09%-864.74K-135.65%-2.91M
Net profit of parent company owners 101.17%39.32M-44.95%35.28M-88.08%9.57M-123.43%-75.85M-91.10%19.54M-58.83%64.08M24.27%80.24M35.62%323.75M10.61%219.5M11.43%155.65M
Earning per share
Basic earning per share 83.33%0.11-47.37%0.1-87.50%0.03-123.40%-0.22-90.63%0.06-58.70%0.19-7.69%0.24-6.00%0.94-23.81%0.64-22.03%0.46
Diluted earning per share 83.33%0.11-47.37%0.1-87.50%0.03-123.16%-0.22-90.63%0.06-58.70%0.19-7.69%0.24-5.00%0.95-23.81%0.64-22.03%0.46
Other composite income -70.68%3.07M68.15%8.03M108.17%237.87K392.20%9.25M814.76%10.47M322.97%4.78M-234.19%-2.91M-810.04%-3.16M44.01%-1.46M-219.52%-2.14M
Other composite income of parent company owners -70.68%3.07M68.15%8.03M108.17%237.87K392.20%9.25M814.76%10.47M322.97%4.78M-234.19%-2.91M-732.79%-3.16M44.70%-1.46M-221.71%-2.14M
Total composite income 7.43%42.57M-41.54%43.3M-88.58%9.56M-119.19%-62.68M-81.75%39.62M-50.82%74.06M31.34%83.71M28.97%326.6M5.16%217.17M0.64%150.6M
Total composite income of parent company owners 41.22%42.39M-37.11%43.31M-87.32%9.81M-120.77%-66.6M-86.23%30.01M-55.14%68.86M21.39%77.33M34.50%320.59M11.35%218.03M8.53%153.51M
Total composite income of minority owners -98.14%178.81K-100.11%-5.64K-103.79%-241.92K-34.82%3.92M1,211.22%9.61M278.94%5.21M18,332.97%6.38M-59.64%6.01M-108.07%-864.74K-135.51%-2.91M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg